Mandibular radiomorphometric assessment of bone mineral density in survivors of pediatric hematopoietic stem-cell transplantation

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
COSTA, Claudio
SALGADO, Daniela Miranda Richarte de Andrade
CORACIN, Fabio Luiz
FAVA, Marcelo
Citação
CLINICS, v.74, article ID e929, 5p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: Hematopoietic stem-cell transplantation (HSCT) childhood survivors of hematologic malignancies are prone to develop late osteopenia and osteoporosis. The purpose of this retrospective study was to quantitatively and qualitatively assess bone mineral density (BMD) in HSCT childhood survivors and to compare the effectiveness of both qualitative and quantitative assessment methods. METHODS: DESIGN BMD assessment using panoramic radiographs of childhood HSCT survivors aged 3.69-18.88 years using two radiomorphometric indexes. Case-control double-blinded comparison of panoramic radiographic images from childhood HSCT survivors and age-and sex-matched healthy controls. Quantitative assessment was performed by measuring the cortical bone width bilaterally at the mental foramen level. Qualitative assessment was performed using the mandibular cortical index bilaterally on all panoramic images. RESULTS: Radiographs were taken 6.59-83.95 months after bone marrow transplantation [median +/- SD=25.92 +/- 24.9 months]. Fifty-two panoramic radiographic images were analyzed: 21 from HSCT survivors and 31 from healthy controls aged 3.69-25.1 years [mean +/- SD=11.89 +/- 5.28 years]. The mandibular cortical bone width was 17% smaller in childhood HSCT survivors than in healthy controls (case group: 2.420, control group: 3.307; p=0.00617). Qualitative analysis revealed an increased frequency of severe mandibular cortical erosion in childhood HSCT survivors, although no significant difference was observed (case group: 1.540, control group: 1.490; p=0.32). The interobserver agreement was 85% (Kappa index). CONCLUSIONS: HSCT childhood survivors exhibit quantitative and qualitative mandibular bone impairments. Further studies are needed to establish an association between mandibular cortical bone impairment and osteoporosis.
Palavras-chave
Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation, Children, Osteoporosis, Radiomorphometric Assessment
Referências
  1. Al-Dam A, 2013, J CRANIO MAXILL SURG, V41, pE165, DOI 10.1016/j.jcms.2012.11.044
  2. Allen B, 2016, INT J PAEDIATR DENT, V26, P330, DOI 10.1111/ipd.12203
  3. Cho WK, 2017, BONE MARROW TRANSPL, V52, P144, DOI 10.1038/bmt.2016.199
  4. Chow EJ, 2016, BIOL BLOOD MARROW TR, V22, P782, DOI 10.1016/j.bbmt.2016.01.023
  5. Ghassemi Ali, 2016, Int J Hematol Oncol Stem Cell Res, V10, P153
  6. Gomes CC, 2014, OSTEOPOROSIS INT, V25, P1885, DOI 10.1007/s00198-014-2696-3
  7. Halling A, 2005, OSTEOPOROSIS INT, V16, P999, DOI 10.1007/s00198-004-1796-x
  8. Kadesjo N, 2018, DENTOMAXILLOFAC RAD, V47, DOI 10.1259/dmfr.20170305
  9. Kang Min Jae, 2013, Korean J Pediatr, V56, P60, DOI 10.3345/kjp.2013.56.2.60
  10. KLEMETTI E, 1994, SCAND J DENT RES, V102, P68
  11. Le Meignen M, 2011, BLOOD, V118, P1481, DOI 10.1182/blood-2011-01-332866
  12. Lin JN, 2017, ONCOTARGET, V8, P34811, DOI 10.18632/oncotarget.16746
  13. Mandel K, 2004, J CLIN ONCOL, V22, P1215, DOI 10.1200/JCO.2004.04.199
  14. Muramatsu C, 2016, INT J COMPUT ASS RAD, V11, P2021, DOI 10.1007/s11548-016-1438-8
  15. Nagi R, 2014, J CLIN DIAGN RES, V8, pZC36, DOI 10.7860/JCDR/2014/9210.4748
  16. Pallagatti S, 2017, OPEN DENT J, V11, P350, DOI 10.2174/1874210601711010350
  17. Pfeilschifter J, 2000, J CLIN ONCOL, V18, P1570, DOI 10.1200/JCO.2000.18.7.1570
  18. Pundole X, 2017, BONE MARROW TRANSPL, V52, P663, DOI 10.1038/bmt.2016.312
  19. Pundole XN, 2015, J CLIN ONCOL, V33, P1364, DOI 10.1200/JCO.2014.57.8195
  20. Taguchi A, 2004, AM J ROENTGENOL, V183, P1755, DOI 10.2214/ajr.183.6.01831755
  21. Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219
  22. Weilbaecher KN, 2000, BIOL BLOOD MARROW TR, V6, P165, DOI 10.1016/S1083-8791(00)70039-5
  23. Wilson CL, 2013, CURR OSTEOPOROS REP, V11, P329, DOI 10.1007/s11914-013-0165-0
  24. Zenlea Ian S, 2017, Hosp Pediatr, V7, P395, DOI 10.1542/hpeds.2016-0213
  25. Zinter MS, 2018, BIOL BLOOD MARROW TR, V24, P330, DOI 10.1016/j.bbmt.2017.10.036